Finding of endocannabinoids in human eye tissues: implications for glaucoma

Area of Science:

• Ophthalmology
• Neuroscience
• Biochemistry

Background:

• Cannabinoid CB(1) receptors influence ocular physiology and intraocular pressure (IOP).
• Endocannabinoid levels in various human ocular tissues remain largely uninvestigated, particularly in glaucoma.
• Key endocannabinoids include anandamide (AEA), 2-arachidonoylglycerol (2-AG), and palmitoylethanolamide (PEA).

Purpose of the Study:

• To quantify endocannabinoid levels (AEA, 2-AG, PEA) in human ocular tissues from normal and glaucomatous donors.
• To investigate potential alterations in endocannabinoid levels associated with glaucoma.
• To explore the role of endocannabinoids in the regulation of intraocular pressure (IOP).

Main Methods:

• Detection and quantification of AEA, 2-AG, and PEA in human cornea, iris, ciliary body, retina, and choroid.
• Comparison of endocannabinoid levels between ocular tissues from normal donors and patients with glaucoma.
• Analysis of endocannabinoid concentrations in relation to IOP regulation.

Main Results:

• AEA, 2-AG, and PEA were detected in all examined human ocular tissues.
• Significantly decreased levels of 2-AG and PEA were observed in the ciliary body of eyes from glaucoma patients.
• No significant changes were noted in other tissues or for AEA levels in the ciliary body.

Conclusions:

• Endogenous cannabinoids, specifically 2-AG and PEA, are present in human ocular tissues.
• Reduced levels of 2-AG and PEA in the ciliary body may be linked to the pathophysiology of glaucoma.
• These findings suggest a potential role for endocannabinoids in the regulation of intraocular pressure and glaucoma development.